Louise E van Eekeren
Overview
Explore the profile of Louise E van Eekeren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Eekeren L, Vadaq N, Blaauw M, Groenendijk A, Vos W, Nelwan E, et al.
BMC Med
. 2025 Feb;
23(1):78.
PMID: 39934780
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a key risk factor for cardiovascular disease (CVD), potentially driven by shared metabolic mechanisms. Metabolic perturbations associated with MASLD and CVD remain...
2.
Navas A, Matzaraki V, van Eekeren L, Blaauw M, Groenendijk A, Vos W, et al.
Aging Cell
. 2025 Jan;
e14468.
PMID: 39812213
Due to the increased burden of non-AIDS-related comorbidities in people living with HIV (PLHIV), identifying biomarkers and mechanisms underlying premature aging and the risk of developing age-related comorbidities is a...
3.
Impact of COVID-19, lockdowns and vaccination on immune responses in a HIV cohort in the Netherlands
Otten T, Jiang X, Gupta M, Vadaq N, Cleophas-Jacobs M, Dos Santos J, et al.
Front Immunol
. 2025 Jan;
15:1459593.
PMID: 39744634
Introduction: During the COVID-19 pandemic, major events with immune-modulating effects at population-level included COVID-19 infection, lockdowns, and mass vaccinations campaigns. As immune responses influence many immune-mediated diseases, population scale immunological...
4.
Meeder E, van Eekeren L, Blaauw M, Groenendijk A, Vos W, van Lunzen J, et al.
Brain Behav
. 2024 Oct;
14(10):e70021.
PMID: 39428553
Objectives: Psychiatric symptoms occur frequently in people living with human immunodeficiency virus (PLWH), which may affect quality of life, sexual risk behavior, and adherence to antiretroviral therapy (ART). Data from...
5.
van Eekeren L, de Mast Q, Meeder E, Navas A, Groenendijk A, Blaauw M, et al.
EBioMedicine
. 2024 Oct;
109():105407.
PMID: 39426127
Background: Insights into the mechanisms driving metabolic dysfunction-associated steatotic liver disease (MASLD) in people living with HIV (PLHIV) remain limited. Plasma proteomics holds promise for biomarker discovery and the elucidation...
6.
Groenendijk A, Afonso P, Wit F, Wit F, Blaauw M, van Eekeren L, et al.
Clin Infect Dis
. 2024 Aug;
PMID: 39208446
Background: We aimed to compare the non-AIDS events (nADE) risk between normal progressors using ART (NP-ART) and people with HIV (PWH) that naturally control HIV infection (HIV controllers), as well...
7.
van Eekeren L, Vadaq N, Vos W, Blaauw M, Groenendijk A, van Lunzen J, et al.
Open Forum Infect Dis
. 2024 Jun;
11(6):ofae266.
PMID: 38868310
Background: Steatotic liver disease is suggested to have a higher prevalence and severity in people with HIV (PHIV), including in those with a normal body mass index (BMI). In this...
8.
Vos W, Navas A, Meeder E, Blaauw M, Groenendijk A, van Eekeren L, et al.
Front Immunol
. 2024 May;
15:1350065.
PMID: 38779686
Introduction: Immunological non-responders (INR) are people living with HIV (PLHIV) who fail to fully restore CD4+ T-cell counts despite complete viral suppression with antiretroviral therapy (ART). INR are at higher...
9.
Vos W, Vadaq N, Matzaraki V, Otten T, Groenendijk A, Blaauw M, et al.
Viruses
. 2024 Apr;
16(4).
PMID: 38675924
In people living with HIV (PLHIV), integrase strand transfer inhibitors (INSTIs) are part of the first-line combination antiretroviral therapy (cART), while non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens are alternatives. Distinct...
10.
Blaauw M, Berrevoets M, Vos W, Groenendijk A, van Eekeren L, Vadaq N, et al.
J Am Heart Assoc
. 2023 Oct;
12(20):e030606.
PMID: 37804189
Background Cardiovascular disease is a major cause of morbidity and mortality in people living with HIV, who are at higher risk than the general population. We assessed, in a large...